Exogenous ciliary neurotrophic factor (CNTF) administration promotes the survival of motor neurons in a wide range of models. It also increases the expression of the critical neurotransmitter enzyme choline acetyltransferase (ChAT) by in vitro motor neurons, likely independent of its effects on their survival. We have used the adult mouse facial nerve crush model and adult-onset conditional disruption of the CNTF receptor a (CNTFRa) gene to directly examine the in vivo roles played by endogenous CNTF receptors in adult motor neuron survival and ChAT maintenance, independent of developmental functions. We have previously shown that adult activation of the CreER gene construct in floxed CNTFRa mice depletes this essential receptor subunit in a large subset of motor neurons (and all skeletal muscle, as shown in this study) but has no effect on the survival of intact or lesioned motor neurons, indicating that these adult CNTF receptors play no essential survival role in this model, in contrast to their essential role during embryonic development. Here we show that this same CNTFRa depletion does not affect ChAT labeling in nonlesioned motor neurons, but it significantly increases the loss of ChAT following nerve crush. The data suggest that, although neither motor neuron nor muscle CNTF receptors play a significant, nonredundant role in the maintenance of ChAT in intact adult motor neurons, the receptors become essential for ChAT maintenance when the motor neurons are challenged by nerve crush. Therefore, the data suggest that the receptors act as a critical component of an endogenous neuroprotective mechanism. J. Comp. Neurol. 525:1206-1215, 2017 
effect on the survival of intact or lesioned motor neurons, indicating that these adult CNTF receptors play no essential survival role in this model, in contrast to their essential role during embryonic development. Here we show that this same CNTFRa depletion does not affect ChAT labeling in nonlesioned motor neurons, but it significantly increases the loss of ChAT following nerve crush. The data suggest that, although neither motor neuron nor muscle CNTF receptors play a significant, nonredundant role in the maintenance of ChAT in intact adult motor neurons, the receptors become essential for ChAT maintenance when the motor neurons are challenged by nerve crush. Therefore, the data suggest that the receptors act as a critical component of an endogenous neuroprotective mechanism. J. Comp. Neurol. 525:1206 -1215 , 2017 . INDEXING TERMS: CNTF receptor a; CNTFRa; inducible Cre recombinase; mouse; RRID:AB_2079760; RRID:SCR_002798; RRID:SCR_002368 Ciliary neurotrophic factor (CNTF) is a potent neuroprotective factor for embryonic motor neurons in vitro . In vivo, CNTF administration protects motor neurons after early postnatal peripheral nerve lesion (Sendtner et al., 1990) , in genetic models of motor neuron disease (Sendtner et al., 1992a; Ikeda et al., 1995; Sagot et al., 1995) , and during developmental naturally occurring motor neuron death (Oppenheim et al., 1991) , suggesting that endogenous CNTF receptor signaling may maintain motor neurons during development and in adulthood.
To determine directly the role(s) of endogenous CNTF receptors in motor neuron maintenance, the receptors must be manipulated in vivo. CNTF receptor a (CNTFRa) is an essential ligand binding subunit of the CNTF receptor, which is composed of CNTFRa, leukemia inhibitory factor receptor b (LIFRb), and gp130 (Davis et al., 1993a) . Although LIFRb and gp130 are found in other related receptors, CNTFRa is unique to CNTF receptors and is required for all known forms of CNTF receptor signaling, regardless of the ligands or signaling pathways involved (Davis et al., 1993a; Elson et al., 2000; Derouet et al., 2004) . Therefore, CNTFRa disruption is the best method for comprehensively determining endogenous CNTF receptor function.
Unconditional disruption of the CNTFRa gene in mice leads to uniform death within 24 hours of birth, accompanied by motor neuron loss (DeChiara et al., 1995) .
Thus, endogenous CNTF receptor signaling is essential for embryonic motor neuron survival/development. However, it is particularly important to identify and characterize the endogenous mechanisms maintaining adult motor neurons because such mechanisms may serve as therapeutic targets for adult-onset motor neuron diseases and trauma. The perinatal death of the unconditional CNTFRa knockout mice precludes their use for adult studies. Moreover, to identify adult functions independent of potential developmental effects, adult-onset disruption is required. Therefore, we have used Cre/loxP technology to deplete CNTFRa in adult facial motor neurons by combining an adult inducible Cre recombinase (Cre) gene construct and floxed CNTFRa mice (Lee et al., 2013a) . We found that, in contrast to the effects of CNTFRa disruption during development, adult disruption did not affect motor neuron survival (Lee et al., 2013a) , indicating that the motor neuron CNTF receptors do not play an essential role in the survival of noninsulted adult motor neurons.
Adult facial motor neurons, unlike early postnatal motor neurons, do not die following nerve crush (Gilad et al., 1996; Kuzis et al., 1999; Lee et al., 2013a) , and this serves as a model to identify endogenous mechanisms maintaining adult motor neurons after insult. Our adult CNTFRa disruption did not affect motor neuron survival following nerve crush (Lee et al., 2013a) , indicating that the receptors are not essential for the survival of the lesioned motor neurons.
However, several studies have indicated that CNTF promotes expression of choline acetyltransferase (ChAT) in cultured motor neurons (Magal et al., 1991; Glicksman et al., 1993; Wong et al., 1993; Kato and Lindsay, 1994; Zurn, 1994) , likely independent of its effects on motor neuron survival (Wong et al., 1993; Zurn, 1994) . These data raise the interesting possibility that endogenous CNTF receptors, although not essential for adult motor neuron survival, play an important role by helping maintain this functionally critical neurotransmitter enzyme in adult motor neurons.
To address this question directly in adult motor neurons in vivo, the experiments reported here used the same adult-onset CNTFRa disruption model with facial nerve crush. The effect of CNTFRa disruption on ChAT was examined in intact and nerve crush-lesioned motor neurons.
MATERIALS AND METHODS General design
For all experiments, homozygous floxed CNTFRa mice and nonfloxed littermate controls were processed in parallel (by individuals kept blind to genotype) throughout the complete procedure, including tamoxifen injection, nerve crush, perfusion, immunohistochemistry/histology, and image analysis. This approach controlled for variability in in utero and postnatal rearing environments as well as any variation in genetic background, age, and all reagents. For statistical analysis we used Student's t-test (for the qRT-PCR comparison of CNTFRa in floxed vs. control mice) or two-way ANOVA analysis, followed by Bonferroni post hoc comparisons (for the ChAT analysis), all conducted in GraphPad (La Jolla, CA) Prism 5 (RRID:SCR_002798; http://www.graphpad.com/scientific-software/prism/). The floxed CNTFRa gene was bred as heterozygote by heterozygote crosses, whereas all other constructs were bred in heterozygote by wild-type crosses. The University of Cincinnati institutional animal care and use committee approved all the animal procedures.
Mouse lines
We have previously described the floxed CNTFRa mice and characterized them (Lee et al., 2008) . Cre activity in these mice leads to functional inactivation of the floxed CNTFRa gene. Crossing them with a "deleter" line that produces universal Cre-dependent floxed gene excision results in the designed excision of the CNTFRa gene (confirmed by Southern blot) as well as the expected motor neuron loss and perinatal death of all homozygous floxed mice (Lee et al., 2008) , as seen with unconditional, universal CNTFRa gene disruption (DeChiara et al., 1995) . CreER mice were generated and initially characterized by Guo et al. (2002) and were purchased for this study from Dr. C. Lobe (Sunnybrook and Women's College, Toronto, Ontario, Canada). ROSA26 reporter mice (Soriano, 1999) were purchased from The Jackson Laboratory (Bar Harbor, ME). All mice (male and female) were genotyped by PCR analysis of tail biopsy DNA and back-crossed for at least five generations onto a 129SvEvBrd background.
Tamoxifen administration
Mice (3-4 months of age) were injected IP with 200 mg/kg tamoxifen (catalog No. T5648; Sigma, St. Louis, MO) made up at 20 mg/ml in corn oil (Sigma; catalog No. C8267).
Facial nerve crush
The previously published protocol of Kuzis et al. (1999) was used to produce unilateral facial nerve crush lesions. Mice were anesthetized with ketamine/ xylazine (100 mg/kg). Skin and muscle were opened by the ear to expose the facial nerve, which was then freed from fascia and crushed (for 10 seconds) with Dumont No. 5 Biologic Tip forceps (catalog No. 11251-20; Fine Science Tools, Foster City, CA).
Anatomical procedures
After overdose with avertin (20 mg/ml, IP), mice were perfused with 4 8C saline and then with 4 8C 4% paraformaldehyde. Brains were removed and postfixed in 4% paraformaldehyde overnight at 4 8C and then cryoprotected for at least 48 hours in 30% sucrose with 2.5 mM sodium azide before sectioning. Muscle was similarly postfixed and cryoprotected. Thirty-micrometer cryostat sections of muscle were stained slide-mounted with standard Xgal histology for the ROSA26 reporter study.
For ChAT immunohistochemistry, every fourth 30-lm coronal cryostat section was collected throughout the complete rostral caudal extent of the facial motor nucleus and processed free-floating with previously described immunohistochemistry procedures (MacLennan et al., 1996) with a rabbit anti-ChAT polyclonal antiserum (catalog No. AB143; Chemicon/Millipore, Temecula, CA; RRID:AB_2079760) at 1:6,000 and visualized with ABC signal amplification (catalog No. PK-6100; Vector Laboratories, Burlingame, CA) and cyanine-3 tyramide (catalog No. SAT704B; Perkin Elmer Life Sciences, Waltham, MA).
ChAT-labeled facial motor neurons were stereologically counted. To correct for cells potentially split in the Z dimension, all motor neurons in focus at the top border of the sections were excluded (optical dissector), in accordance with the stereological methods described by Hyman et al. (1998) and Hatton and Von Bartheld (1999) . Counts were multiplied by four to estimate total labeled motor neurons, given that every fourth section was assayed and counted. MetaMorph image analysis software (RRID:SCR_002368; Molecular Devices, Sunnyvale, CA; https://www.moleculardevices. com) was used to outline the cytoplasm of each labeled motor neuron and to determine its average cytoplasmic ChAT labeling intensity. Just as with all procedures, this analysis was conducted by individuals unaware of genotype. Motor neurons were categorized into 10 ChAT labeling intensity ranges determined a priori, with 0 equal to background and 100 corresponding to the most intensely labeled motor neuron in the entire study. The ninth and tenth categories were then combined for graphical presentation because so few motor neurons were found in these highest labeling intensity categories.
Antibody characterization
The ChAT antiserum has been widely used and extensively characterized. Its pattern of immunolabeling is confined to areas known to express detectable levels of ChAT (German et al., 1985; Peterson et al., 1990; Smith et al., 1993 Smith et al., , 1994 . The immunolabeling also corresponds to that seen with other anti-ChAT antibodies (Stillman et al., 2009; McKenna et al., 2013 ; Table 1 ). Moreover, preadsorption of the antiserum with recombinant rat ChAT protein abolished labeling (Stillman et al., 2009) . Finally, Western blot characterization of the antiserum with human brain and placental tissue produced a distinct band at 68 kDa that corresponds to the molecular weight of enzymatically active ChAT (Bruce et al., 1985) .
Microscopy
A 12-megapixel DXM1200 camera and an E800 microscope (Nikon, Tokyo, Japan) with a 3 10 (NA 0.45) lens were used to capture images. The brightness and contrast of the images for the figures were adjusted in Corel Draw (Corel, Ottawa, Ontario, Canada). 
qRT-PCR

RESULTS
To disrupt facial motor neuron CNTF receptors starting in adulthood, we bred together the floxed CNTFRa gene and a gene construct (CreER) allowing tamoxifeninducible Cre activity (Guo et al., 2002) . We have previously shown, with a reporter gene, that adult induction of CreER leads to Cre activity (i.e., floxed gene excision) in approximately half of facial motor neurons (Lee et al., 2013a) and that it also leads to the corresponding loss of all detectable CNTFRa in approximately half of the facial motor neurons in homozygous floxed CNTFRa mice (referred to hereafter as floxed CNTFRa mice; Lee et al., 2013a) , which is expected because the floxed CNTFRa gene is designed to be disrupted by Cre activity. This loss of motor neuron CNTFRa in the floxed CNTFRa mice is also consistent with all our previous work with these same floxed mice and several different Cre lines in which Cre activity, as indicated by reporter signals, reliably disrupted CNTFRa in a variety of cell types (Stefater et al., 2012; Lee et al., 2013b,c) .
Because the CreER construct does not lead to Cre activity prior to the tamoxifen induction (Guo et al., 2002; Lee et al., 2013a) , the effects of this adult induction reflect adult CNTFRa loss. It is worth noting that there are no methods of which we are aware that lead to adult-onset floxed gene disruption in all motor neurons. We have subsequently discovered that the adult CreER induction also leads to reporter-visualized Cre activity in all skeletal muscle fibers, including those in all facial muscles (Fig. 1) . Skeletal muscle contains CNTF receptors (Helgren et al., 1994) , which could play a role in motor neuron maintenance (see Discussion). Therefore, we used qRT-PCR to confirm directly that the same adult CreER induction protocol used in our previous motor neuron survival study (Lee et al., 2013a) reduces facial muscle CNTFRa RNA in floxed CNTFRa mice, as expected from the reporter data. Floxed CNTFRa mice and nonfloxed littermate controls (all CreER 1 ) were treated with tamoxifen at 3-4 months of age, and temporal muscle was dissected 4 months later. The floxed CNTFRa muscle contained 32.7% 6 4.6% as much CNTFRa RNA as controls (t 5 3.43; P 5 0.011; N 5 3 floxed CNTFRa, N 5 6 controls). This degree of CNTFRa RNA depletion without complete removal is consistent with what we have found with other gene constructs driving Cre activity in skeletal muscle of the floxed CNTFRa mice (Lee et al., 2013b) and what others have found targeting different floxed genes with Cre in skeletal muscle (Bothe et al., 2000; Wredenberg et al., 2002) . It may result from Cre induction in most but not all of the many nuclei in each myofiber, such that at least some reporter signal is generated in all myofibers (as we observe), but not all the many copies of the floxed CNTFRa gene in each myofiber are excised. Regardless, the depletion of muscle CNTFRa in the floxed CNTFRa mice with CreER, considered in the context of our previous finding that motor neuron survival is not affected in these mice even after nerve lesion (Lee et al., 2013a) , suggests that neither motor neuron nor muscle CNTFRa play a significant, essential role in the survival of adult intact or nerve crushlesioned motor neurons (see also Discussion). We next used the same CreER/floxed CNTFRa model to determine whether in vivo CNTF receptors play an essential role in maintaining adult motor neuron ChAT. Floxed CNTFRa mice and nonfloxed littermate controls were given tamoxifen at 3-4 months of age. They then received a unilateral facial nerve crush 4 months later. The mice were perfused for ChAT immunohistochemistry 3 weeks after the lesion (Fig. 2) . Image analysis consisted of counting ChAT-labeled motor neurons in each facial motor nucleus and determining the average cytoplasmic ChAT labeling intensity of each motor neuron.
The adult-onset depletion of CNTFRa clearly did not decrease ChAT labeling in intact facial motor neurons, given that the CNTFRa-depleted mice displayed at least as many ChAT-labeled intact motor neurons as controls. If anything, there was a trend toward an increase in ChAT-labeled motor neurons in some labeling intensity ranges (Fig. 3A) . However, with appropriate multiplecomparison post hoc tests, this trend did not reach significance at any labeling intensity (Fig. 3A) .
Comparison of the intact and lesioned facial motor neurons within the controls indicated that the nerve crush produced a small (statistically insignificant) decrease in ChAT labeling (Fig. 3B ), in line with previous cranial nerve crush data (Armstrong et al., 1991) . In contrast, the identical nerve crush in the CNTFRadepleted mice produced a large, highly significant decrease in ChAT labeling (Fig. 3C) . The betweenanimal comparison of lesioned motor neurons in control vs. CNTFRa-depleted mice likewise indicated significantly less ChAT labeling in the CNTFRa-depleted mice (Fig. 3D ), although the difference was not as great as that seen with the within-animal comparisons, given the trend to less ChAT-labeled motor neurons in the controls. Finally, the overall ANOVA genotype-by-lesion interaction term also indicated that the lesion had a significantly larger effect on ChAT labeling in the CNTFRadepleted mice than in the controls, even when the data were collapsed across all labeling intensities (F 5 5.14; P < 0.05).
DISCUSSION
This article describes more of our continuing effort to determine the in vivo roles played by endogenous CNTF Figure 2 . Adult-onset CNTFRa gene disruption with CreER decreases facial motor neuron ChAT labeling following nerve crush. Homozygous floxed CNTFRa mice and littermate nonfloxed controls, all containing CreER, were injected with tamoxifen at 3-4 months of age to deplete motor neuron and muscle CNTFRa, specifically in the floxed mice. Four months later they all received a unilateral facial nerve crush. Three weeks after the lesion their facial motor nuclei were examined by ChAT immunohistochemistry. Examples of sections from control, nonfloxed (A) and CNTFRa-depleted, floxed (B) mice are shown with the lesioned side on the right. The clusters of labeled motor neurons correspond to the facial motor nuclei. This qualitative decrease in ChAT labeling was observed throughout the lesion side, CNTFRa-depleted facial motor nuclei (every fourth section assayed; see Materials and Methods). Quantification is shown in Figure 3 . The images for A and B were identically captured and adjusted for brightness and contrast. Scale bar 5 100 mm.
receptors in maintaining adult motor neurons. We used floxed CNTFRa mice and CreER to produce an adultonset CNTFRa gene disruption. We have previously shown that this eliminates CNTFRa labeling in approximately half of facial motor neurons but has no effect on motor neuron survival even following nerve crush, suggesting that adult motor neuron CNTF receptors do not play an essential role in adult motor neuron survival under these conditions (Lee et al., 2013a) . The present finding that the identical CreER/floxed CNTFRa manipulation also depletes skeletal muscle CNTFRa suggests that adult muscle CNTF receptors likewise do not make a significant, essential contribution to the survival of intact or nerve crush-lesioned adult motor neurons. The substantial depletion but not complete removal of muscle CNTFRa leaves open the possibility that muscle CNTFRa contributes to motor neuron survival, such that even a small amount of muscle CNTFRa is sufficient to provide maximal effect. However, it seems most likely that, if muscle CNTFRa were to play a significant, essential role, its substantial depletion would produce at least a trend toward an effect on survival, which was not seen (Lee et al., 2013a) . Moreover, as discussed below, this same manipulation produces a large effect on ChAT in lesioned motor neurons, indicating that any role played by adult CNTF receptors in Figure 3 . Quantitative analysis of facial motor neuron ChAT labeling following nerve crush in control and CNTFRa-depleted mice. After adult-onset CNTFRa depletion, nerve crush, and ChAT immunohistochemistry (see Fig. 2 ), the average cytoplasmic ChAT labeling intensity was determined in MetaMorph software for each labeled facial motor neuron. Motor neurons were then categorized into 10 ChAT labeling intensity ranges determined a priori, with 0 equal to background and 100 corresponding to the most intensely labeled motor neuron in the entire study. The ninth and tenth categories are combined here for graphic presentation because so few motor neurons were found in these categories. A: CNTFRa depletion did not decrease ChAT labeling in intact (i.e., nonlesioned) motor neurons. The CNTFRa-depleted mice displayed a trend toward increased labeled neurons in some labeling intensity ranges, but none reached significance with appropriate multiple-comparison post hoc statistics. B: Nerve crush in control (i.e., not CNTFRa depleted) mice led to a trend toward decreased ChAT labeling that was not significant at any labeling intensity. C: In contrast, nerve crush in CNTFRa-depleted mice led to a large, highly significant decrease in ChAT labeling. D: The between-mice comparison of ChAT labeling in lesioned motor neurons of controls vs. CNTFRa-depleted mice also revealed a significant decrease in ChAT labeling with CNTFRa depletion, even with the trend for less overall ChAT labeling in the control mice. Finally, ANOVA of all the data, collapsing across all labeling intensities, also indicated that the lesion had a significantly larger effect on ChAT labeling in the CNTFRa-depleted mice than in the controls (see Results). N 5 4 CNTFRa-floxed mice; N 5 7 control mice. Data are mean 6 SEM. *P < 0.05, **P < 0.01, ***P < 0.001, Bonferroni post hoc tests, compared with intact CNTFRa-depleted motor neurons in C and lesioned control motor neurons in D. motor neuron survival is at least much less than their contribution to motor neuron ChAT maintenance.
We show that the depletion of adult motor neuron and muscle CNTFRa does not decrease motor neuron ChAT labeling in intact motor neurons, suggesting that CNTF receptors do not play a significant, essential role in maintaining ChAT levels in intact adult motor neurons. However, the same CNTFRa depletion leads to a decrease in ChAT labeling in nerve-lesioned motor neurons that is significantly larger than that seen in controls, suggesting that, with this insult, motor neuron and/or muscle CNTF receptors become essential for maintaining motor neuron ChAT levels. In other words, the data suggest that, although adult CNTF receptors are not essential for maintaining motor neuron ChAT levels in the absence of insult, they adopt such a role when the motor neurons are challenged by nerve crush.
It is theoretically possible that the depletion of CNTFRa from roughly half of the motor neurons does not affect ChAT in the nonlesioned motor neuron population because the remaining receptor activity in the motor neurons with CNTFRa somehow maintains ChAT in the motor neurons with depleted CNTFRa through some sort of noncell autonomous process. However, this unlikely scenario would be of more concern were we not to have observed any effect of the CreER/floxed CNTFRa manipulation and were concluding that adult CNTFRa does not play any role in motor neuron ChAT maintenance. Instead, we observed a large effect of the CreER/floxed CNTFRa manipulation in lesioned motor neurons, which indicates that, even if an unlikely noncell-autonomous process is involved, it is not enough to compensate entirely for the loss of CNTFRa. It remains remotely possible that a noncell-autonomous process masks a role for CNTFRa in maintaining ChAT in nonlesioned motor neurons but is not enough to mask the larger role of CNTFRa in lesioned motor neurons.
Although the mechanisms by which CNTFRa helps to maintain ChAT are not currently known, adult motor neuron CNTFRa could obviously contribute to motor neuron CNTF receptor signaling that helps to maintain motor neuron ChAT, which is suggested by the in vitro data (see below). Muscle CNTFRa could contribute to muscle CNTF receptor signaling, leading to increased release of one or more yet-to-be-identified muscle factors that act on motor neurons to maintain ChAT. Another interesting possibility involves the release of muscle CNTFRa itself. CNTFRa is attached to the extracellular surface of the plasma membrane by a glycosylphosphatidylinositol linkage. After nerve lesion, muscle CNTFRa is released in a soluble, functional form (Davis et al., 1993b ) that could potentially, over time, diffuse to axons proximal to the lesion and enhance motor neuron CNTF receptor signaling. Unfortunately, the optimal conditions for CNTFRa and ChAT immunohistochemistry were not compatible for double labeling. Therefore, we were unable to determine whether the effect of the CreER/floxed CNTFRa manipulation on motor neuron ChAT levels is restricted primarily to the subpopulation of motor neurons lacking CNTFRa, which would be expected if motor neuron CNTFRa is responsible primarily for maintaining motor neuron ChAT, or occurs independently of which motor neurons are CNTFRa depleted, which would be expected if muscle CNTFRa plays a significant role.
Although motor neurons and muscle are the only cell types expressing CNTFRa in the neuromuscular system (Davis et al., 1991; MacLennan et al., 1996; Lee et al., 1997) , we cannot exclude the unlikely possibility that motor neuron ChAT is somehow indirectly maintained by CNTFRa in some class of nonneuromuscular cells that may also be affected by CreER induction in floxed CNTFRa mice. In addition, it is worth noting that CNTFRa RNA has been detected in peripheral nerve in some (Kirsch et al., 1998) but not other studies (Mata et al., 1993; Kirsch and Hofmann, 1994) and is never anatomically localized to nerve soma (Kirsch et al., 1998) . Immunohistochemistry detects nerve CNTFRa protein exclusively in axons (MacLennan et al., 1999) , suggesting that the CNTFRa RNA nerve signal reflects axonal CNTFRa RNA, consistent with several reports of motor neuron RNA in peripheral nerve axons (Jung et al., 2012) . However, even if nerve soma express some CNTFRa RNA, it is unlikely that the effect of the CreER/floxed CNTFRa manipulation in the current study resulted from disrupting such expression because CreER induction does not lead to Cre activity in peripheral nerve soma (data not shown).
Regardless of the cell types involved, the present data demonstrate for the first time that adult CNTF receptors can help to maintain motor neuron ChAT in vivo. Clearly, future cell-type specific, adult-onset CNTFRa gene targeting will be required to definitively determine the cellular location(s) of the critical receptors.
We targeted CNTFRa because CNTFRa disruption is the most comprehensive approach for determining the in vivo functions of endogenous CNTF receptor signaling. CNTFRa is required for all forms of CNTF receptor signaling, regardless of which ligands and signaling pathways are involved (Davis et al., 1993a; Elson et al., 2000; Derouet et al., 2004) . Consequently, the present data do not address which individual ligands or pathways are responsible for the motor neuron ChAT maintenance following nerve crush. CNTF may play a role, given that it is apparently released from peripheral nerve Schwann cells at the lesion site (Sendtner et al., 1992b) and could act on either motor neuron (axonal) or muscle CNTF receptors. Motor recovery following sciatic nerve crush is decreased in unconditional CNTF knockout mice (Yao et al., 1999) , consistent with endogenous CNTF contributing to neuromuscular maintenance/recovery after the injury. However, this unconditional knockout study did not address the cellular source of the CNTF or whether the knockout affects motor neuron ChAT levels. The complex of cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/ CLF1) also serves as a CNTF receptor ligand (Elson et al., 2000) and is another viable candidate for participation in motor neuron ChAT maintenance. Unlike CNTF, CLC/CLF1 plays an essential role in maintaining motor neurons during development. Thus, complete unconditional knockout of CLF1 (Alexander et al., 1999; Elson et al., 2000; Forger et al., 2003) , CLC (Zou et al., 2009 ), or CNTFRa (DeChiara et al., 1995 but not CNTF (Masu et al., 1993; DeChiara et al., 1995) leads to substantial perinatal motor neuron loss. However, adult neuromuscular CLC/CLF expression has yet to be examined. Both CNTF and CLC/CLF may contribute to the adult ChAT maintenance found here and may act together. Adult-onset disruption of the individual ligands is required to address this issue definitively, with celltype-specific disruption identifying the cellular source of each ligand.
The present data showing no loss of motor neuron ChAT with adult-onset CNTFRa disruption in intact (nonlesioned) motor neurons may, at least initially, appear to contrast with the multiple findings that exogenous CNTF can help maintain ChAT in embryonic cultured motor neurons (Magal et al., 1991; Glicksman et al., 1993; Wong et al., 1993; Kato and Lindsay, 1994; Zurn, 1994) . Although this difference may result from distinctive properties of embryonic vs. adult motor neurons and/or the in vivo vs. in vitro conditions, it is worth noting that the cultured motor neurons were, of course, axotomized and, perhaps, were a better model for the lesioned adult motor neurons in the mice used here, in which we found a decrease in ChAT when the CNTF receptor was disrupted, consistent with the in vitro data.
Motor neuron ChAT is a critical enzyme absolutely required for neuromuscular transmission. Therefore, motor neuron ChAT loss has significant functional consequences. The present data showing that adult CNTF receptors maintain in vivo ChAT levels in motor neurons challenged by insult raise the possibility that specific targeting of these receptors may be therapeutic in adult neuromuscular diseases, such as human amyotrophic lateral sclerosis, in which motor neurons challenged by the disease display decreased ChAT prior to their eventual death (Kato, 1989; Oda et al., 1995) . Enhancing adult motor neuron CNTF receptor signaling may delay or block this ChAT loss and the resulting functional impairment. It also remains possible that the ChAT loss is a precursor event leading to the subsequent motor neuron degeneration such that promoting motor neuron ChAT maintenance through CNTF receptor signaling could significantly slow the progression of the disease. Finally, an analogous argument could be made for CNTF receptor-based therapeutics and the treatment of peripheral nerve injury.
